GILD

Gilead Sciences Inc

Jun 02 • 04:00PM ET

127.57

-3.53 -2.69 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: AMGN REGN VRTX BIIB ABBV BMY LLY MRK ALNY ARGX

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.36	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-4.61%
Market Cap	158.39B	Forward P/E	13.22	EPS next Y	9.65	Insider Trans	-18.22%	Shs Float	1.24B	Perf Month	-3.10%
Enterprise Value	170.66B	PEG	1.44	EPS next Q	-6.59	Inst Own	88.82%	Short Float	1.87%	Perf Quarter	-13.70%
Income	9.22B	P/S	5.32	EPS this Y	-100.73%	Inst Trans	-1.42%	Short Ratio	3.78	Perf Half Y	1.37%
Sales	29.79B	P/B	6.74	EPS next Y	16229.26%	ROA	16.35%	Short Interest	23.14M	Perf YTD	3.94%
Book/sh	18.93	P/C	16.13	EPS next 5Y	9.15%	ROE	43.19%	52W High	157.29 -18.90%	Perf Year	17.13%
Cash/sh	7.91	P/FCF	15.48	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 22.12%	Perf 3Y	63.78%
Dividend Est.	3.24 (2.54%)	EV/EBITDA	11.56	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.74% 2.49%	Perf 5Y	93.20%
Dividend TTM	3.19 (2.50%)	EV/Sales	5.73	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.36	Perf 10Y	47.11%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	37.98	Recom	1.52
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-3.75%	Beta	0.33	Target Price	160.72
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-5.30%	Rel Volume	1.32	Prev Close	131.10
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	-0.92%	Avg Volume	6.12M	Price	127.57
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	8,078,242	Change	-2.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)